Furthermore, in the circulation, the PAD group had lower antioxidant capacity, higher levels of inflammation as measured by numerous biomarkers, and lower angiogenic biomarkers of VEGF-A and HGF. This evidence concerns the gene HGF and peripheral arterial disease.